CuriRx Incorporation

CuriRx Incorporation is a contract services company located in Wilmington, Massachusetts, specializing in research and development for biotech and pharmaceutical products. Founded in 2012, the company boasts 37 employees and generates annual revenue of $1 million. CuriRx provides a wide range of services, including formulation development, lyophilization, cell culture and purification, and analytical development. They also offer non-GMP vial production for animal studies and non-GMP stability support studies. CuriRx's team of scientists possesses over 30 years of combined experience in formulation development and has successfully worked with diverse product types, encompassing small molecules, peptides, proteins, vaccines, biosimilars, oligonucleotides, and more. What sets CuriRx apart is their dedication to strong collaboration and customized development plans. They foster open communication and consultative expertise, employing an iterative ideation process to maximize efficacy and ensure customer satisfaction. CuriRx also extends its expertise through consultation services in areas such as operational management, project management, GMP, cGMP, aseptic technique training, and product development. Interested parties can learn more about CuriRx and explore open positions by visiting their website at curirx.com. Their career page provides detailed information about current openings, including roles such as Scientist, Mass Spectrometry, Senior Controller, Senior IT Support Technician, QA Manager, and QA Associate.